Key result
Hyperbaric oxygenation increased the survival rate from 90.4% to 97.1% compared to standard therapy in patients with acute and chronic forms of ischemic heart disease.
Why the study?
Does hyperbaric oxygenation improve survival in patients with acute and chronic ischemic heart disease?
RCT (n=3,020)
Open-label
Random number table
No
Does hyperbaric oxygenation improve survival in patients with acute and chronic ischemic heart disease?
Absolute Risk Reduction: 6.7
Absolute Event Rate: 97.1% vs 90.4%
Absolute Risk Reduction: 6.7%
p-value: p=0.001
Hyperbaric oxygenation may significantly improve long-term survival in patients with acute and chronic ischemic heart disease, particularly when revascularization is not possible.
No takes yet. Share an insight, caveat, or question.
Hyperbaric oxygenation improves survival in ischemic heart disease; extends options especially when revascularization is not possible.
D. P. Salivonchyk (2012) conducted an RCT in Ischemic heart disease (acute and chronic forms) (n=3,020). Hyperbaric oxygenation (HBO) vs. Standard therapy was evaluated on Survival rate (ARR 6.7%, p=0.001). Hyperbaric oxygenation increased the survival rate from 90.4% to 97.1% compared to standard therapy in patients with acute and chronic forms of ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: